|
Structural rearrangement signatures as novel biomarkers for homologous recombination deficiency in cancer
|
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
Investigating the Role of the MYCN Oncogene in Regulating Chemokine Expression in Neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS |
St. Jude Children’s Research Hospital |
The RUNX1 Research Program |
|
Creating an Infrastructure for Collaborative Clinical Research and Publication of Consensus Guidelines for RUNX1 Familial Platelet Disorder |
The Cleveland Clinic Foundation |
The RUNX1 Research Program |
|
A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia |
University of Colorado Denver_ Anschutz Medical Campus |
Northwestern Mutual Foundation |
|
Arginine Depletion with DFMO in High-Risk Neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
CDK8 as a New Therapeutic Target in Alveolar Rhabdomyosarcoma |
Dana-Farber Cancer Institute |
The Maddox Potter Foundation |
|
Targeting the Checkpoint Receptor TIGIT via CRISPR/Cas9 Genome Editing to Enhance NK Cell Anti-Tumor Activity |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
|
In Situ CD19.CAR-T Generation Using TRIDENT System for Pediatric B Cell Malignancies |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation, Tap Cancer Out |
